NP-12 is a peptide antagonist of the PD-1 signaling pathway, which acts as an immunomodulatory agent for cancer therapy.
CAT No: R1566
CAS No: 1353564-66-5
Synonyms/Alias: Tideglusib;865854-05-3;NP-12;NP031112;Tideglusib [INN];4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione;NP-031112;tideglusibum;Zentylor;Nypta;NP 031112;UNII-Q747Y6TT42;Q747Y6TT42;TIDEGLUSIB [WHO-DD];CHEBI:147398;DTXSID90235682;4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione;2-(1-naphthalenyl)-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione;4-BENZYL-2-(A-NAPHTHYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE;4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione;Zentylor nypta;MFCD18633296;1,2,4-Thiadiazolidine-3,5-dione, 2-(1-naphthalenyl)-4-(phenylmethyl)-;Tideglusib(NP-031112);1353564-66-5;SCHEMBL676929;Tideglusib(NP-031112)?;GTPL6929;CHEMBL3545157;Tideglusib, >=98% (HPLC);DTXCID20158173;EX-A600;HMS3673G17;HMS3744E05;HMS3884J18;4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione;4-benzyl-2-(naphthalene-1-yl)-1,2,4-thiadiazolidine-3,5-dione;BCP06016;Tideglusib,CAS:865854-05-3;BDBM50166940;NSC800950;s2823;AKOS025149085;CCG-267855;CS-0613;DB12129;FT30356;NSC-800950;SB19268;SDCCGSBI-0654483.P001;Tideglusib (NP031112, NP-12);Tideglusib (NP-031112, NP-12);NCGC00386380-06;AC-31056;AS-56156;DA-41071;DA-56282;HY-14872;NS00071037;BRD-K81330143-001-02-2;BRD-K81330143-001-04-8;Q10382411;945421-01-2;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C19H14N2O2S |
M.W/Mr. | 334.4 |
Sequence | One Letter Code: H-SNTSESFKF(H-SNTSESF)RVTQLAPKAQIKE-NH2 three Letter Code: Ser-Asn-Thr-Ser-Glu-Ser-Phe-Lys(Ser-Asn-Thr-Ser-Glu-Ser-Phe)-Phe-Arg-Val-Thr-Gln -Leu-Ala-Pro-Lys-Ala-Gln-Ile-Lys-Glu-NH2 |
InChI | InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2 |
InChI Key | PMJIHLSCWIDGMD-UHFFFAOYSA-N |
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.